Specific features of the allozyme structure of dandelion populations under conditions of radionuclide and chemical contamination

A study of allozyme spectra has been performed in dandelion cenopopulations growing for a long time under conditions of chemical pollution (the zone of the Nizhnii Tagil Metallurgical Plant, NTMP) or radioactive contamination (the zone of the Eastern Ural Radioactive Trace, EURT). Cenopopulations from the NTMP and EURT zones and from the background area differ significantly in the qualitative and quantitative composition of allozyme phenes. An analysis of clonal diversity has shown that all cenopopulations are phenogenetically unique. The genesis of each cenopopulation proceeded in a specific way: they had different sets of progenitor plants, whose descendants varied genetically in the course of their reproduction and more or less successful colonization of habitats, undergoing selection under the impact of natural environmental factors and technogenic stress. An increased variability of enzyme systems, compared to the sample from the background area, and, as a consequence, reduced clonal diversity may be regarded as a trait common to populations exposed to chemical or radiation stress.     

A RAWLSIAN EVALUATION OF IRRIGATION DISTRIBUTION IN INDIA1

ABSTRACT: This paper critically evaluates the nature of irrigation distribution in India using the Rawlsian criterion of equity in dis. tribution and estimates the performance of different states in India according to the Rawlsian notion of fairness in distribution. It is found that there is considerable inequality across farm-size groups in the distribution of irrigated areas in general and canal irrigated areas in particular, and that there are wide interstate differences in the levels of this inequality. Further, it is found that switching over to a Rawlsian based distribution of canal irrigation will help in reducing the levels of inequality in overall irrigation distribution in all states.     

Alpha-fetoprotein in fetal serum,amniotic fluid,and maternal serum

In order to gain more insight into the association between alpha-fetoprotein (AFP) and fetal chromosomal disorders, especially Down's syndrome, we measured AFP in fetal serum, amniotic fluid, and maternal serum at cordocentesis. We compared the concentration and gradient of AFP in these three compartments. Our data confirm earlier findings on second-trimester fetal serum AFP concentration. The results indicate that low maternal serum AFP in pregnancies with fetal chromosomal disorders could result from an impaired fetal kidney function as well as from impaired membrane or placental passage of AFP, rather than from reduced fetal AFP production.     

Repeat maternal serum testing in multiple marker down's syndrome screening programmes

The effect of repeat testing in maternal serum multiple marker screening for Down's syndrome was estimated using samples stored in an antenatal serum bank. Human chorionic gonadotropin (hCG) and unconjugated oestriol (uE₃) levels were determined in 142 pairs of routinely collected samples which had already been tested for alpha-fetoprotein (AFP). For each marker, about two-thirds of the pairs of values were within 20 per cent of each other and most were within 40 per cent. A multivariate Gaussian model was used to estimate the detection and false-positive rates for different repeat testing policies. A policy of repeat testing those with a high risk of a Down's syndrome term pregnancy given age and marker levels would reduce the false-positive rate but there would also be a reduction in the detection rate. For example, using all three markers and a 1 in 250 cut-off risk, the estimated false-positive rate would fall from 5·3 to 3·8 per cent but the detection rate would decrease from 58 to 55 per cent. A policy of repeating those with either high or borderline risks would produce a modest improvement in screening efficiency. Repeating the 11 per cent with a risk exceeding 1 in 500 yields an estimated false-positive rate of 5·0 per cent and a detection rate of 60 per cent. A policy of selective repeat testing is not recommended as it would not substantially improve screening efficiency. Nonetheless, if a repeat test has been performed, the parameters given in this paper will enable an unbiased estimate of the Down's syndrome risk to be calculated for individual women.     

对我国海洋环境监测工作的若干建议

本文在回顾和总结我国海洋环境监测多年成就的基础上，分析了海洋环境质量发展的趋势，指出随着沿海经济及海洋资源开发活动的深入发展，近岸海洋环境将面临的前所未有的压力。为此，未来我国海洋环境监测的重点是近岸水域，尤其是各类入海污染源及其邻近海域，监工作必须由近海向近岸及重点海域转移。     

The impact of prenatal diagnosis on the occurrence of chromosome abnormalities

From the public health point of view, several formal attempts have been made to measure the impact of prenatal diagnosis (PND) on the incidence of Down's Syndrome (DS), but the results have varied widely. The impact of PND (reduction in the birth rate of chromosomally abnormal neonates) is related to utilization rates but quantitative estimates of this have not been established. In a three-year (1981–1983) total population study from Queensland, Australia, we present results to measure the impact of a voluntary PND programme on the birth incidence of DS, and also other chromosomally abnormal births. Utilization rates for the PND service were 15·5 per cent in that population of mothers 35 years and over. Numbers and rates of all cases of chromosomal abnormalities are presented, subclassified by type of diagnosis–-either by PND or by clinical diagnosis after birth. For the total population, 7·3 per cent of cases of DS were detected prenatally, and 15·4 per cent of all chromosome abnormalities. (A method for measuring the impact of PND is described.) Using this in conjunction with our demographic data, we estimate that with a 15 per cent utilization rate of PND by older mothers, 14 per cent of DS births can be prevented in this age group, or a 5 per cent overall reduction can be achieved if mothers of all ages are considered. One index–-the ratio of the percentage of DS births which are preventable compared with the population utilization rates of PND–-has potential for widespread use. Queensland data for this ratio is 0·34, a figure consistent with that from other studies. Thus a 3·5 per cent drop in the overall DS birth rate may be expected for each 10 per cent increase in the utilization rates of PND for mothers of 35 years and over. A diagram is presented which may serve as a model for improved data collection and better impact estimates in the future.     

Second-trimester maternal serum screening using alpha-fetoprotein,human chorionic gonadotrophin,and unconjugated oestriol: Experience of a regional programme

Over a 2-year period from January 1991 to December 1992, second-trimester maternal serum screening for Down's syndrome using alpha-fetoprotein (aFP), human chorionic gonadotrophin (hCG), and unconjugated oestriol (uE₃) was made available to five health districts in East Anglia, with a total population of 1·2 million. Amniocentesis was offered when the risk of Down's syndrome at term was 1:200 or greater. 25359 singleton pregnancies were screened, representing an uptake of 77 per cent. The recall rate for the 24 per cent of women who had not had a dating scan prior to the test was 9·4 per cent compared with 3·9 per cent for those who had been scanned (P<0·0005). Seventy-five per cent (36/48) of Down's syndrome pregnancies were detected for a false-positive rate of 4·0 per cent. Twenty-five out of 36 of detected Down's syndrome pregnancies were dated by scan prior to sampling, and in the 11 remaining cases, the dates were confirmed by scan after a high-risk result was obtained. The exclusion of uE₃ from the screening protocol would have reduced the detection rate to 52 per cent (25/48) for the same false-positive rate. Eighty-five per cent of women identified at high risk accepted the offer of an amniocentesis. Other fetal abnormalities detected were trisomy 18 (3), trisomy 13 (2), 45,X (6), 69,XXX (5), other chromosome abnormalities (9), open neural tube defects (26), hydrocephalus (7), abdominal wall defects (4), and steroid sulphatase deficiency (6).     

养殖海水中有机磷农药的毛细管气相色谱分析

本文介绍了毛细管气相色谱测定养殖海水中一组化学结构上相近、且被广泛使用的有机磷农药分析方法。样品经ＣＨＣｌ３萃取，无水Ｎａ２ＳＯ４脱水和Ｋ－Ｏ浓缩器后，用装有ＦＰＤ检测器的毛细管气相色谱测定。在本分析方法中设置的色谱条件下，该组有机磷农药能够被较好的分离；０．０１５、０．１５和１．５ｍｇ／Ｌ量级的添加部回收率为９７．８±８．７％－－１０３．３±６．７％，变异系数为３．６－７．８，本方法的了低检出浓